# A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

> **NCT00398996** · PHASE3 · COMPLETED · sponsor: **Centre for the AIDS Programme of Research in South Africa** · enrollment: 642 (actual)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Early versus intermediate versus late initiation of ART

## Key facts

- **NCT ID:** NCT00398996
- **Lead sponsor:** Centre for the AIDS Programme of Research in South Africa
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 642 (ACTUAL)
- **Last updated:** 2011-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398996, "A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00398996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*